J&J and Pharmacyclics announce advances in drug for treatment of chronic lymphocytic leukemia (“CLL”). Phase III testing indicates that the drug elongates patients’ lives and delays progression of CLL. Check it out at http://news.yahoo.com/j-j-pharmacyclics-leukemia-drug-succeeds-stage-study-151022757–finance.html;_ylt=A2KJ3Cf6dcxSnEIA9w_QtDMD